Please use this identifier to cite or link to this item: http://dx.doi.org/10.14279/depositonce-8664
Main Title: The reimbursement of new medical technologies in German inpatient care: What factors explain which hospitals receive innovation payments?
Author(s): Ex, Patricia
Vogt, Verena
Busse, Reinhard
Henschke, Cornelia
Type: Article
Language Code: en
Is Part Of: 10.14279/depositonce-6687
Abstract: Most hospital payment systems based on diagnosis-related groups (DRGs) provide payments for newly approved technologies. In Germany, they are negotiated between individual hospitals and health insurances. The aim of our study is to assess the functioning of temporary reimbursement mechanisms. We used multilevel logistic regression to examine factors at the hospital and state levels that are associated with agreeing innovation payments. Dependent variable was whether or not a hospital had successfully negotiated innovation payments in 2013 (n = 1532). Using agreement data of the yearly budget negotiations between each German hospital and representatives of the health insurances, the study comprises all German acute hospitals and innovation payments on all diagnoses. In total, 32.9% of the hospitals successfully negotiated innovation payments in 2013. We found that the chance of receiving innovation payments increased if the hospital was located in areas with a high degree of competition and if they were large, had university status and were private for-profit entities. Our study shows an implicit self-controlled selection of hospitals receiving innovation payments. While implicitly encouraging safety of patient care, policy makers should favour a more direct and transparent process of distributing innovation payments in prospective payment systems.
URI: https://depositonce.tu-berlin.de/handle/11303/9618
http://dx.doi.org/10.14279/depositonce-8664
Issue Date: 4-Jun-2019
Date Available: 15-Jul-2019
DDC Class: 610 Medizin und Gesundheit
330 Wirtschaft
Subject(s): adjustment
DRG system
hospital financing
innovation payments
reimbursement
new medical technologies
technological innovation
Sponsor/Funder: BMBF, 01EH1604A, Berliner Zentrum der Gesundheitsökonomischen Forschung
License: https://creativecommons.org/licenses/by-nc-nd/4.0/
Journal Title: Health economics, policy and law
Publisher: Cambridge University Press
Publisher Place: Cambridge
Volume: 14
Publisher DOI: 10.1017/S1744133119000124
EISSN: 1744-134X
ISSN: 1744-1331
Appears in Collections:FG Management im Gesundheitswesen » Publications

Files in This Item:
File Description SizeFormat 
Ex_etal_2019.pdf1.64 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons